Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction

Next Previous
X
Search
Trial Profile

Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 May 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel; Lansoprazole
  • Indications Haemorrhage; Myocardial infarction; Stroke; Thrombosis
  • Focus Therapeutic Use
  • Acronyms PRAGUE-18

    • Most Recent Events

    • 01 Sep 2020 Results of a post hoc analysis of the multicenter randomized PRAGUE-18 study, presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
    • 01 Sep 2020 Results presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
    • 01 Aug 2020 Results evaluating CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel or ticagrelor treated STEMI patients, published in the Xenobiotica
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top